Skip to main content
. Author manuscript; available in PMC: 2012 Sep 3.
Published in final edited form as: Mol Psychiatry. 2011 Apr 12;16(10):1024–1038. doi: 10.1038/mp.2011.36

Figure 6.

Figure 6

Effect of unilateral and bilateral intra-central amygdala microinjection of the D1 dopamine receptor antagonist SCH23390 on anxiety-like behavior in the elevated plus-maze test. (A) The percentage of open arm entries. (B) The percentage of time spent in the open arms. n = 13–16 mice per group. **p < 0.01 compared with the vehicle-treated fWT littermate control group;##p < 0.01,###p < 0.001 compared with the vehicle-treated LeprDAT-Cre group. (C) Schematic illustration of unilateral (left panel) and bilateral (right panel) injection sites in the central amygdala (top) and representative ink injections showing the deposition site within the central amygdala (bottom). All data are expressed as mean ± SEM.